» Articles » PMID: 31941355

Scaffolds for Knee Chondral and Osteochondral Defects: Indications for Different Clinical Scenarios. A Consensus Statement

Abstract

Objective: To develop patient-focused consensus guidelines on the indications for the use of scaffolds to address chondral and osteochondral femoral condyle lesions.

Design: The RAND/UCLA Appropriateness Method (RAM) was used to develop patient-specific recommendations by combining the best available scientific evidence with the collective judgement of a panel of experts guided by a core panel and multidisciplinary discussers. A list of specific clinical scenarios was produced regarding adult patients with symptomatic lesions without instability, malalignment, or meniscal deficiency. Each scenario underwent discussion and a 2-round vote on a 9-point Likert-type scale (range 1-3 "inappropriate," 4-6 "uncertain," 7-9 "appropriate"). Scores were pooled to generate expert recommendations.

Results: Scaffold (chondral vs. osteochondral), patient characteristics (age and sport activity level), and lesion characteristics (etiology, size, and the presence of osteoarthritis [OA]) were considered to define 144 scenarios. The use of scaffold-based procedures was considered appropriate in all cases of chondral or osteochondral lesions when joints are not affected by OA, while OA joints presented more controversial results. The analysis of the evaluated factors showed a different weight in influencing treatment appropriateness: the presence of OA influenced 58.3% of the indications, while etiology, size, and age were discriminating factors in 54.2%, 29.2%, and 16.7% of recommendations, respectively.

Conclusions: The consensus identified indications still requiring investigation, but also the convergence of the experts in several scenarios defined appropriate or inappropriate, which could support decision making in the daily clinical practice, guiding the use of scaffold-based procedures for the treatment of chondral and osteochondral knee defects.

Citing Articles

Arthroscopic debridement followed by intra-articular injection of micro-fragmented adipose tissue in patients affected by knee osteoarthritis: Clinical results up to 48 months from a prospective clinical study.

Bruno A, Anzillotti G, De Donato M, Basso M, Tamini J, Dupplicato P J Exp Orthop. 2025; 12(1):e70144.

PMID: 39830171 PMC: 11739897. DOI: 10.1002/jeo2.70144.


Theranostic Applications of Scaffolds in Current Biomedical Research.

Patil S, Thorat V, Koparde A, Bhosale R, Bhinge S, Chavan D Cureus. 2024; 16(10):e71694.

PMID: 39559663 PMC: 11571282. DOI: 10.7759/cureus.71694.


Cell-free biomimetic osteochondral scaffold for the treatment of knee articular surface lesions: Clinical outcomes differ based on patient and lesion characteristics.

De Marziani L, Boffa A, Andriolo L, Di Martino A, Romandini I, Solaro L Knee Surg Sports Traumatol Arthrosc. 2024; 33(2):544-554.

PMID: 39101253 PMC: 11792099. DOI: 10.1002/ksa.12402.


Addressing meniscal deficiency part 2: An umbrella review of systematic reviews and meta-analyses on meniscal scaffold-based approaches.

Wu K, Therien A, Kiwinda L, Castillo C, Hendren S, Long J J Exp Orthop. 2024; 11(3):e12108.

PMID: 39050593 PMC: 11267169. DOI: 10.1002/jeo2.12108.


Acellular Aragonite-Based Scaffold for the Treatment of Joint Surface Lesions of the Knee: A Minimum 5-Year Follow-Up Study.

De Caro F, Vuylsteke K, Van Genechten W, Verdonk P Cartilage. 2024; 15(4):399-406.

PMID: 38899593 PMC: 11520016. DOI: 10.1177/19476035241227346.


References
1.
Fischer S, Kisser A . Single-step scaffold-based cartilage repair in the knee: A systematic review. J Orthop. 2016; 13(4):246-53. PMC: 4925898. DOI: 10.1016/j.jor.2016.06.004. View

2.
Angele P, Niemeyer P, Steinwachs M, Filardo G, Gomoll A, Kon E . Chondral and osteochondral operative treatment in early osteoarthritis. Knee Surg Sports Traumatol Arthrosc. 2016; 24(6):1743-52. DOI: 10.1007/s00167-016-4047-8. View

3.
Kon E, Filardo G, Brittberg M, Busacca M, Condello V, Engebretsen L . A multilayer biomaterial for osteochondral regeneration shows superiority vs microfractures for the treatment of osteochondral lesions in a multicentre randomized trial at 2 years. Knee Surg Sports Traumatol Arthrosc. 2017; 26(9):2704-2715. PMC: 6105149. DOI: 10.1007/s00167-017-4707-3. View

4.
Dhollander A, Guevara Sanchez V, Almqvist K, Verdonk R, Verbruggen G, Verdonk P . The use of scaffolds in the treatment of osteochondral lesions in the knee: current concepts and future trends. J Knee Surg. 2012; 25(3):179-86. DOI: 10.1055/s-0032-1322596. View

5.
Kon E, Robinson D, Verdonk P, Drobnic M, Patrascu J, Dulic O . A novel aragonite-based scaffold for osteochondral regeneration: early experience on human implants and technical developments. Injury. 2017; 47 Suppl 6:S27-S32. DOI: 10.1016/S0020-1383(16)30836-1. View